News

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...
J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.
Bengaluru: Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide, including in India.
Bob Lane discusses his experience with prostate cancer, and describes what survivorship and cure means to him as someone ...
Associated Medical Professionals offers multimodal artificial intelligence test to identify prostate cancer treatment plans for Central NY patients.
If you or someone you know has received a prostate cancer diagnosis, here's where to start, what to ask and how to plan ...
“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...
Prostate cancer is one of the most common cancers in men, but when caught early, it's highly treatable. For Vernon Owens, a ...
American Oncology Institute (AOI) at Citizens Specialty Hospital, Hyderabad, has successfully managed a complex and rare case ...
Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).
The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...